Why Is GE HEALTHCARE TECHNO (GEHC) Stock Up Today?
By the Top Tier Newswire AI Desk · July 30, 2026 at 12:12 AM ET · reviewed against 25 wire stories
GE HEALTHCARE TECHNO (GEHC) is up +12.15% in the latest session. Our newswire has captured 25 stories on GEHC across 14 sources in the last 36 hours, with AI sentiment reading bullish (avg 60/100).
GEHC stock rose 12.15% to $71.90 on July 29, 2026, driven by strong second-quarter results and updated guidance from the company. The firm reported adjusted earnings per share of $1.13, exceeding estimates, and reaffirmed its 2026 guidance. Record orders and a strategic review of its Patient Care Solutions unit added to the positive momentum.
What Happened
GE HealthCare Technologies Inc. delivered a second-quarter 2026 performance that exceeded expectations, with revenue of $5.30 billion, adjusted EBIT of $750 million, and adjusted EPS of $1.13, all above forecasts. The company reported a record backlog and strong order growth, despite divergent performance across its business segments. Management reaffirmed its 2026 adjusted EPS guidance of $4.80 to $5.00 and outlined a strategic review of its Patient Care Solutions unit. The results prompted BTIG to raise its price target to $79 and maintain a Buy rating. The stock’s sharp rise also followed a series of insider purchases and a recent uptick in congressional trading activity.
What The Data Shows
Over the last eight sessions, GEHC has gained 13.9%, rising from $63.14 to $71.90. The stock currently trades within its 52-week range of $58.75 to $89.77. The company’s fundamentals include a market cap of $27.8 billion, a P/E ratio of 15.4, and trailing twelve-month revenue growth of 6.0%. Recent insider transactions include three purchases totaling $805,000 in the last 90 days, with no sales reported. Congressional trades show six buys and six sells in the same period. The stock’s beta of 0.84 suggests it is less volatile than the broader market.
What To Watch
The company’s next key event will be its third-quarter 2026 earnings report, which is expected to provide further insight into its strategic review and operational performance. Investors should also monitor the breadth of coverage and any follow-up analyst ratings in the coming weeks.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Not financial advice.
BTIG raises GE HealthCare stock price target to $79 on strong orders
BTIG raises GE HealthCare stock price target to $79 on strong orders
14h agoYahoo FinanceNEUTRAL 50Earnings
GE HealthCare Technologies Inc. Q2 2026 Earnings Call Summary
Moby summary of GE HealthCare Technologies Inc.
15h agoSeeking AlphaBULLISH 56Earnings
GE HealthCare targets 3% to 4% organic sales growth and $4.80 to $5 adjusted EPS in 2026 while reviewing Patient Care Solutions options
GE HealthCare (GEHC) Q2 2026 earnings call recap: record orders/backlog, guidance maintained, PCS strategic review, and key risks—read the insights now.
15h agoSeeking AlphaNEUTRAL 50Earnings
GE HealthCare Technologies Inc. (GEHC) Q2 2026 Earnings Call Transcript
GE HealthCare Technologies Inc. (GEHC) Q2 2026 Earnings Call July 29, 2026 8:30 AM EDTCompany ParticipantsCarolynne Borders - Chief Investor Relations...
16h agoThe Motley FoolBULLISH 63Earnings
Here's Why GE Healthcare Shares Popped Higher Today
Cost increases have hit the company in 2026, but today's earnings report provides evidence of an oncoming improvement.
16h agoInvesting.com MarketsBULLISH 63Earnings
GE HealthCare tops quarterly estimates, weighs patient care unit sale
GE HealthCare tops quarterly estimates, weighs patient care unit sale
17h agoMarketChameleonBULLISH 63Earnings
GE HealthCare Delivers Record Orders and Reaffirms 2026 Guidance Amid Segment Divergence
July 29, 2026
GE HealthCare's second quarter 2026 results reveal strong orders growth and a resilient backlog, despite divergent performance across its key business segments. The company reaffirms its 2026 guidance and continues to invest in innovation, while addressing ongoing challenges in Patient Care Solutions.
17h agoYahoo FinanceNEUTRAL 54Earnings
S&P 500 Stocks: GEHC Revives, Humana Fades On Earnings
17h agoBarron'sBULLISH 68Earnings
GE HealthCare Stock Soars After Earnings—and It’s Suddenly the Best Performing GE
GE HealthCare reports earnings per share of $1.13 from sales of $5.3 billion. Wall Street was looking for $1.04 a share and $5.3 billion, respectively.
Frequently asked questions
Why is GEHC stock up today?
GE HEALTHCARE TECHNO (GEHC) is up +12.15% in the latest session. Our newswire has captured 25 stories on GEHC across 14 sources in the last 36 hours, with AI sentiment reading bullish (avg 60/100). The most recent driver: "GE HealthCare Technologies Inc. 2026 Q2 - Results - Earnings Call Presentation" (Seeking Alpha).
Is GEHC a buy right now?
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of GEHC coverage reads 60/100 over 25 stories; treat it as a research signal and do your own diligence.
How fast does this page update?
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →